Low HIV, HBV, HCV Seroprevalence and inadequate HBV Vaccination in Sickle Cell Patients in Abakaliki, Nigeria: Urgent Need for Surveillance and Adult Vaccination
Low HIV, HBV, HCV Seroprevalence and Inadequate HBV Vaccination in Sickle Cell Patients
DOI:
https://doi.org/10.60787/tnhj.v24i3.856Keywords:
Hepatitis B, Hepatitis C, HIV, Sickle cell disease, VaccinationAbstract
Background: Frequent hospitalization, blood transfusion, unsafe care seeking practices, and self-administration of injectable opioid analgesics could pose significant risk of Hepatitis B, C and HIV infections for patients with Sickle Cell Disease (SCD) due to chronic anaemia and bone pains. Study evaluated the prevalence of hepatitis B, C, HIV, and HBV vaccination status among SCD patients in Abakaliki.
Method: A case-control study of 244 SCD and non-SCD patients was performed. Blood samples were collected and tested for anti-HBV, HIVand HBsAg. Socio-demographic data, knowledge of HBV infection and self-reported HBV vaccination status were ascertained with pre-tested questionnaires. Data were analysed with descriptive statistics, Chi-square/Fishers exact test.
Result: Seroprevalence rates of hepatitis B, C and HIV among patients with SCD and controls were 3.3%, 0.8% and 1.6% vs 21.1%, 0.8% and 2.4% respectively. Blood transfusion posed the highest risk of acquiring HBV infection. Two patients that tested positive to HIV had history of sexual intercourse without blood transfusion. Awareness of HBV infection and vaccination were low among the patients with SCD. Only 8.2% of the SCD patients had received HBV vaccination. The commonest reason for not receiving HBV vaccination was not being aware of it.
Conclusion: The seroprevalence of hepatitis B, C, HIV infections in SCD patients is low and there are other routes of infection aside blood transfusion. Knowledge of HBV infection and vaccination coverage is low among patients with SCD. Surveillance, patient education, and HBV vaccination are highly needed for this at-risk group of patients.
Downloads
References
Thomson AM, McHugh TA, Oron AP, Teply C, Lonberg N, Tella VV et al. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study. Lancet Haematology, 2023;10 (8): e585-e599.
Okoroiwu HU, Okafor IM, Asemota EA, Okpokam DC. Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven-year evaluation. BMC Public Health. 2018 ;18(1):645. doi: 10.1186/s12889-018-5555-x
Hsu YC, Huang DQ, Nguyen M.H. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol.2023; 20: 524–537 https://doi.org/10.1038/s41575-023-00760-9
Ajuwon BI, Yujuico I, Roper K, Richardson A, Sheel M, Lidbury BA. Hepatitis B virus infection in Nigeria: a systematic review and meta-analysis of data published between 2010 and 2019. BMC Infect Dis 21, 1120 (2021). https://doi.org/10.1186/s12879-021-06800-6
Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 2015; 386:1546–55.doi:10.1016/S0140-6736(15)6141
Aliyu GG, Aliyu SH, Ehoche A, Dongarwar D, Yusuf RA, Aliyu MH, Salihu HM. The Burden of HIV, Hepatitis B and Hepatitis C by Armed Conflict Setting: The Nigeria AIDS Indicator and Impact Survey, 2018. Ann Glob Health. 2021 Jun 25;87(1):53 doi: 10.5334/aogh.3226
Ogbenna A, Adewoyin SA, Famuyiwa CO, Oyewole KM, Oyedeji OA, Akanmu AS. Pattern of Blood Donation and Transfusion Transmissible Infections in a Hospital-Based Blood Transfusion Service in Lagos, Nigeria. West Afr J Med. 2021 Nov 30; Vol. 38(11):1088-1094. PMID: 34922408.
Diaku-Akinwumi IN, Abubakar SB, Adegoke SA, Adeleke S, Adewoye O, Adeyemo T, et al. Blood transfusion services for patients with sickle cell disease in Nigeria. Int Health. 2016;8(5):330–5. doi: 10.1093/inthealth/ihw014.
Odaiba G, Babalola O, Akpa, O, Fasola F, Odetunde, A, Brown B, Alamukii N, Babalola C, Falusi, A. Prevalence of HIV, HBV and HCV Infections among Sickle Cell Disease Patients in Southwestern Nigeria: A Case-Control Study. World Journal of AIDS. 2021, 11; 101-119. doi: 10.4236/wja.2021.113009.
Babatola A O, Olatunya O S, Faboya A O, Ojo T O, Kayode S T, et al. Hepatitis B and C Infections Among Pediatric Patients with Sickle Cell Disease at a Tertiary Hospital in Nigeria. Arch Pediatr Infect Dis. 2020;8(4):e101632. https://doi.org/10.5812/pedinfect.101632.
Akpan IS, Onukak AE, Edet IV, Oyewumi AO. The burden of human immunodeficiency virus, hepatitis B and C virus infections in patients with sickle cell anemia in Uyo, Nigeria: A hospital based cross-sectional study. Int J Blood Transfus Immunohematol 2021; 11:100066Z02IA2021
Seck M, Senghor AB, Loum M, Touré SA, Faye BF, Diallo AB, Keita M, Bousso SE, Guèye SM, Gadji M, Sall A, Touré AO, Diop S. Transfusion Practice, Post-Transfusion Complications and Risk Factors in Sickle Cell Disease in Senegal, West Africa. Mediterr J Hematol Infect Dis. 2022;14(1):e2022004. doi: 10.4084/MJHID.2022.004.
Nnachi OC, Akpa CO, Nwani FO, Edenya OO. Pentazocine Misuse among Sickle Cell Disease Patients and The Role of Lack of Enforcement of Opioid Dispensing Regulations by Community Pharmacies: A Descriptive Observational Study. Adv Public Health. 2022, Article ID 3877882, 6 pageshttps://doi.org/10.1155/2022/3877882
Babatola A O, Olatunya O S, Faboya A O, Ojo T O, Kayode S T. Hepatitis C and B I nfections Among Paediatric Patients with Sickle cell Disease at a Tertiary Hospital in Nigeria. Arch Pediatr Infect Dis. 2020;8(4):e101632. https://doi.org/10.5812/pedinfect.101632.
Ophori EA, Tula MY, Azih AV , et al Current trends of immunization in Nigeria: prospect and challenges. Trop Med Health 2014; 42:67–75.doi:10.2149/tmh.2013-13
Ochu CL, Beynon CM. Hepatitis B vaccination coverage, knowledge and sociodemographic determinants of uptake in high-risk public safety workers in Kaduna State, Nigeria: a cross-sectional survey. BMJ Open 2017;7:e015845. doi: 10.1136/bmjopen-2017-015845
Master S, Patan S, Cingam S, Mansour RP. Prevalence ofchronic hepatitis B, hepatitis C and HIV in adult patients withsickle cell disease. Blood. 2016; 128:4863–3.
Geraldine, M., Justin, V., Sheila, U. et al. Haemoglobin electrophoresis in diagnosing a case of sickle cell anaemia associated with β-thalassemia. Indian J Clin Biochem 16, 211–212 (2001). https://doi.org/10.1007/BF02864864
WHO Guidelines on Hepatitis B and C Testing. Geneva: World Health Organization; 2017 Feb. 5, BACKGROUND – DIAGNOSTICS FOR TESTING FOR HEPATITIS B AND C INFECTION. Available from: https://www.ncbi.nlm.nih.gov/books/NBK442281/
Diarra AB, Guindo A, Kouriba B, Dorie A, Diabaté DT, Diawara SI, Fané B, Touré BA, Traoré A, Gulbis B, Diallo DA. Sécurité transfusionnelle et drépanocytose à Bamako, Mali. Séroprévalence des infections à VIH, VHB, VHC et allo-immunisation anti-Rh et Kell chez les drépanocytaires [Sickle cell anemia and transfusion safety in Bamako, Mali. Seroprevalence of HIV, HBV and HCV infections and alloimmunization belonged to Rh and Kell systems in sickle cell anemia patients]. Transfus Clin Biol. 2013 Dec;20(5-6):476-81. French. doi: 10.1016/j.tracli.2013.04.111.
Bolarinwa RA, Aneke JC, Olowookere SA, Salawu L. Seroprevalence of transfusion transmissible viral markers in sickle cell disease patients and healthy controls in Ile-Ife, South-Western Nigeria: A case– control study. J Appl Hematol 2015;6(4):162–7.
Jibrin B, Jiya NM, Ahmed H. Seroprevalence of hepatitis C virus antibody and its associated risk factors in children with sickle cell anaemia. Sub-Saharan Afr J Med 2014; 1:20-5
Mawuli, G., Dzudzor, B., Tachi, K. et al. Hepatitis C virus (HCV) infection among patients with sickle cell disease at the Korle-Bu teaching hospital. Virol J. 2022;19(1):73. .https://doi.org/10.1186/s12985-022-01797-z
Ségbéna AY, Prince-David M, Kagoné TS, Dagnra AY. Virus de l'immunodéficience humaine et virus des hépatites virales C et B chez les patients drépanocytaires au CHU Campus de Lomé (Togo) [Human immunodeficiency virus, hepatitis C virus and hepatitis B viruses in patients with sickle-cell disease in Togo]. Transfus Clin Biol. 2005;12(6):423-6. French. doi: 10.1016/j.tracli.2005.12.003
Abiodun PO, Fatunde OJ, Flach KH, Buck T. Increased incidence of hepatitis B markers in children with sickle-cell anemia. Blut 1989;58(3):147–50
Angyo IA, Okuonghae HO, Yakubu AM. Hepatitis B surface antigenaemia in children with sickle cell anaemia in Jos University Teaching Hospital, Nigeria. Nig Med Pract 1988; 36:15–7.
Owusu EDA, Visser B J, Nagel I M, Mens PF, Grobusch MP. The Interaction Between Sickle Cell Disease and HIV Infection: A Systematic Review. Clinical Infectious Diseases 2015;60(4):612–26
Niazkar HR, Dorgalaleh A, Rad F. First-time Blood Donors Are Double-edged Swords for Blood Transfusion Centers: A Retrospective Study in Southwest Iran. Turk J Hematol 2020; 37:30-35
Usanga VU, Ukwah BN, Kalu ME, Azi SO, Elom MO, Nworie A. Seroprevalence of Hepatitis C Virus (HCV) among students of a Nigerian tertiary institution. I.J.S.N., VOL.11 (4) 2020: 80-84
Obeagu, E., Chima, C. O., Nwosu, D. C., Opara, A. U., Dike-Ndudim, J. N, Ahiara, C. O. and Obeagu, E. I. (2022). Studies On Hepatitis B Virus Infection in Ebonyi State Nigeria Using Hbsag as Markers: Rapid Assessment Survey. Madonna University journal of Medicine and Health Sciences ISSN: 2814-3035. 2(1):185-203
National Agency for the Control of AIDS (NACA). (2019b). Nigeria Prevalence Rate – NACA Nigeria. [online] Naca.gov.ng. https://www.naca.gov.ng/nigeria-prevalence-rate/
Oleske JM, Spiegel HML, Makani J, Scolpino A, Singh S, Shah K et al. Potential Protective Effect of Sickle Cell Gene Allele on HIV Infection. Acad J Ped Neonatol l. 2017; 2(5): 555600. DOI: 10.19080/AJPN.2017.02.555600.
Berger EA, Doms RW, Fenyö EM, Korber BT, Littman DR, Moore JP et al. (1998) A New Classification for HIV-1. Nature. 1988; 391(6664): 240.
Eni AO, Soluade MG, Oshamika OO, Efekemo OP, Igwe TT, Onile-Ere OA. Knowledge and Awareness of Hepatitis B Virus Infection in Nigeria. Ann Glob Health. 2019;85(1):56. doi: 10.5334/aogh.33.
Orji C, Chime O,Nwoke IN, Madu A, Aneke T. Knowledge of hepatitis B virus infection and vaccination status among college of medicine students in Enugu State, south-east, Nigeria. Annals of Clinical and Biomedical Research 2020; 1(90):8-13
Smith DR, Leggat PA. Needle stick and sharp injuries among nursing students. J Adv Nursing 2005; 51:449-55.39.
Deisehammer S, Radon K, Nowak D, Reichert J. Needlestick injuries during medical training. J Hosp Infect 2006; 63:263-7.40.
Al-Busafi SA, Alwassief A. Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030. Vaccines (Basel). 2024;12(3): 288. doi: 10.3390/vaccines12030288
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Oluomachi Charity Nnachi, Favour Ogonna Nwani, Chinedu Obasi Akpa, John C. Akulue, Innocent Paul Ezenwenyi, Favour E Nwadum
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to editor@tnhjph.com.
